ICG to Assess Ovarian Perfusion

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
Fibroid UterusEndometriosisUterus MyomaUterine FibroidUterine AdenomyosisEndometrial CystUterine Cyst
Interventions
DRUG

ICG

Indocyanine green (ICG) is a Food and Drug (FDA)-approved tricarbocyanine dye that is fluorescent under near-infrared (NIR) light. ICG solutions for injection often contain sodium iodide. ICG is water soluble and when introduced intravenously, it is bound by plasma proteins, namely albumin. The intravascular half-life of ICG is 3-4 minutes with rapid hepatic clearance.

Trial Locations (1)

60611

259 E Erie - Northwestern, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03927651 - ICG to Assess Ovarian Perfusion | Biotech Hunter | Biotech Hunter